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Congestive heart failure (CHF) is the most common 
reason for hospitalization in people aged 65 years and 
older in the United States. Especially, a very high rate 
of unplanned readmissions within 30 days of discharge 
due to CHF occurs a heavy associated financial burden 
and degraded quality of care. To effectively prevent 
CHF readmission and improve overall care, this paper 
proposes SwellFit, a novel wearable sensor that helps 
outpatients to proactively monitor a physical symptom 
of worsening CHF, ankle swelling. Using a flex sensor, 
SwellFit monitors changes in ankle curvature as an 
indication of swelling. A pilot test with 4 adults showed 
that SwellFit successfully distinguish noise data and 
motion artifacts from ankle swelling. Collaborating with 
cardiac experts, we are currently planning to test 
SwellFit with hospitalized CHF patients who have 
swelling conditions to demonstrate the feasibility and 
reliability of SwellFit on detecting swelling from ankle 
curvature. 
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Congestive heart failure (CHF) is a chronic condition in 
which the heart is unable to pump sufficiently to 
maintain blood flow to meet the body's needs. Its 
physical symptoms include shortness of breath, fatigue, 
swollen legs, and rapid heartbeat. While all conditions 
of CHF cannot be reversed, treatments such as 
medications and lifestyle modifications can improve the 
symptoms.  
Nearly 6 million Americans suffer from CHF. As the 
most common diagnosis in patients 65 and older in the 
United States, CHF is known as a leading cause of 
hospitalization and readmission: close to 1 million 
hospitalizations for CHF occur annually [7], and more 
than 25 percent of patients hospitalized for CHF are 
readmitted to the hospital within 30 days of discharge 
[9]. Such high rates of hospitalization and readmission 
result in a huge hospital cost and degraded quality of 
care [11]. Thus, improved management of the 
condition is needed to reduce morbidity and mortality, 
as well as to lower the costs of treatment associated 
with CHF. 
To cope with the huge medical and financial burden 
caused by CHF, researchers and medical practitioners 
have sought ways to prevent rehospitalization of CHF 
patients. A common approach has been to teach and 
support outpatients to engage in self-monitoring, which 
involves self-weighing, monitoring of symptoms, and 
the interpretation of changes in weight and symptoms. 
In this paper, we propose a complementary approach 
to support self-monitoring using a personal wearable 
sensor, SwellFit. This novel wearable sensor helps 
patients to proactively monitor a physical sign of 
worsening CHF, ankle swelling. 
A pilot test with 4 adults showed that SwellFit 
successfully distinguished noise data and motion 
artifacts from ankle curvature values. We are currently 
collaborating with cardiac experts to plan testing 
SwellFit with hospitalized CHF patients who have 
swelling conditions to demonstrate the reliability of CHF 
on detecting swelling from changes in ankle curvature. 
We are hopeful that our system could result in reduced 
readmission rates and enhanced self-care practices of 
CHF. 
Existing practices for preventive care 
Diverse interventions have been proposed and are 
being operated to prevent readmissions of CHF 
patients. Two prevalent interventions are phone-based 
remote monitoring and in-home telemonitoring. 
Phone-based remote monitoring 
The most common effort to prevent CHF readmission is 
through regular structured telephone contacts between 
patients and healthcare providers. To structure phone- 
based remote monitoring, several strategies have been 
proposed, including transitional care interventions [12], 
post-discharge care plans [10], and intensive remote 
nursing care [15]. Studies have shown that that nurse-
directed phone-based interventions can reduce 
readmission rates and length of hospital stay in CHF 
patients [14]. However, this intervention relies heavily 
on patients’ manual measuring and monitoring of their 
conditions. Thus, it could lose reliability if patients are 
not cooperative or lack self-monitoring skills.  
Automatic telemonitoring 
A number of automatic telemonitoring systems have been 
developed to support distant monitoring of CHF [5]. These 
systems consisted of electronic equipment that patients 
  
use to enter their symptoms and relevant biomarkers 
such as weight, blood pressure, and heart rate [e.g., 3, 4, 
6]. For example, a home monitoring system that 
measures weight on a daily basis was found to reduce the 
length of CHF patients’ stay at the hospital [2]. CARDIAC 
is an intelligent conversational assistant that provides 
distant CHF monitoring through [8]. Alluhaidan also 
introduced an mHealth system to automatically monitor 
CHF patients’ condition from distance [1].  
This approach has advanced phone-based remote 
monitoring by enabling automatic data transfer from 
patients to care providers. However, it still requires 
patients to manually measure or to enter biomarkers to 
the system, which could involve human errors. 
Furthermore, most data are not continuously monitored 
but measured periodically (once a day or less often) so 
that it could fail to capture critical signs of worsening CHF 
that might happen in between measures. To cope with 
this problem and further enhance self-management of 
CHF, we aim to design a wearable device that 
continuously monitors CHF patients’ condition and inform 
them early enough when a sign of worsening CHF is 
detected.  
Proposed system: SwellFit 
Our goal was to create a wearable sensor that can 
monitor a physical symptom associated with worsening 
CHF with minimal effort required of patients. One early 
physical sign of worsening CHF is swelling of the lower 
body. Due to reduced blood, fluid accumulates in the 
lower part of the body, which causes swelling (and 
edema later on). Currently, there is no systematic 
mechanism to monitor swelling, except a simple visual 
checkup or measuring the diameter of an ankle using a 
tape measure. We focused on ankle swelling, because 
modern sensing technologies can easily detect a very 
small change in ankle swelling by monitoring changes 
in an ankle curvature.   
Measuring ankle curvature for swelling has several 
advantages compared to measuring ankle diameter. 
First, to measure diameter accurately, a person has to 
measure at the exact same location of an ankle every 
time (intra-rater reliability). Second, manual measuring 
of an ankle diameter could be different from a person 
who measures it (inter-rater variability). In contrast, 
continuous monitoring of an ankle’s curvature allows us 
to detect swelling regardless of the location of 
measurement without a measurer, as it continuously 
compares changes in the ankle curvature with previous 
values in real time.  
To that end, we implemented SwellFit, a personal, non-
obtrusive, wearable sensor that monitors ankle swelling 
by measuring an ankles curvature (See Figure 1). Our 
proposed system enables continuous, more accurate, 
less variable, and more sensitive measurement of ankle 
swelling with minimal efforts from patients compared to 
traditional measurements.  
System development 
Our system consists of three parts: a hardware sensing 
platform, software with a backend database for storing 
and visualizing data, and signal processing to translate 
flex sensor values to swelling. (See Figure 2) 
Hardware 
SwellFit hardware comprises of five components; two 
flex sensors, an accelerometer, a microcontroller, a 
bluetooth LE module, and a battery with a battery 
charging station (See Figure 2). The flex sensor detects 
bending in a direction: as a flex sensor is bent, its 
    
 
Figure 1. Final SwellFit 
implementation. Its form factor 
is similar to a sweatband. 
 
 
Figure 2. SwellFit parts consist 
of two flex sensors, a Flora 
wearable electronic platform, a 
Flora wearable Bluetooth 
module, a Flora wearable 
accelerometer, a battery 
charging station, and a battery. 
Parts were connected using 
conductive thread on a fabric 
substrate to create a flexible 
wearable that would not 
interfere with the flex sensor’s 
range of motion. 
 
  
resistance changes from 10kw to about 20kw, and our 
system monitors this resistance change. Two flex 
sensors are connected to wrap completely around an 
ankle, using a voltage divider with a 10kw reference. 
The output of flex sensors is sampled at 200Hz and the 
average value is recorded every second, resulting in an 
effective 1Hz sampling rate.  
 
Figure 3: Data transfer between parts: From left to right, 
SwellFit hardware, an iPod Touch, and a webserver. First, 
sensor readings from SwellFit are transferred to an iPod Touch 
via Bluetooth. Then, an iPod Touch sends the data to a server 
for signal processing through Wi-Fi. Finally, an iPod Touch 
receives the processed data for visualization from the server. 
Additionally, we used an accelerometer to sample 
acceleration of the ankle at 4Hz (the minimum 
frequency to detect steps) [13]. The magnitude of the 
acceleration was calculated using the three-dimensional 
Pythagoras’ theorem. Lastly, a Bluetooth Low Energy 
module was used to transmit sensor readings from the 
microcontroller to an iPod Touch. Data to transmit 
consist of timestamp, raw flex-sensor value, detected 
step (1 or 0) from an accelerometer, and battery value. 
Software 
As soon as an iPod Touch receives data from the 
hardware part, it sends the data to a web server for 
signal processing via Wi-Fi (to be described in the next 
section). Swelling values are then sent back to an iPod 
Touch to render changes in ankle swelling as a graph 
using Swift (See Figure 4). When the system 
determines abnormal swelling, it prompts a push 
notification. In addition, the iPod Touch also renders 
step counts to provide a user’s activity levels. 
Signal processing 
As soon as the web server receives new data, it starts 
processing the data using a Python script as following.  
First, to remove noise and to distinguish motion 
artifacts from actual swelling, we smooth the data 
using a moving average filter. We evaluated several 
window sizes for moving average in order to reduce 
noise without overly smoothing the data. For each 
window size N from 2*fs to 14*fs with fs (Frequency of 
sampling) being 1Hz (a sampling rate), we calculated 
the moving average as a vector. Then, we calculated 
the difference between the raw sensor values and each 
one of the vectors. Lastly, we took a first order 
difference of the means of the difference (the 
unnormalized error) to find the index (i) of the first 
value below a threshold. We selected N = i-k where N 
is greater than 0.  Through the evaluation, we found k 
= 3 to be the best. (See Figure 5)  
Next, to classify the smoothed flex sensor data into 
four categories (normal, false negative, swelling, and 
false positive), we used k-Means as an unsupervised 
clustering method. We first defined the error vector as 
the normalized error between the raw data and the 
smoothed data. Using this error vector, we created a 
two-dimensional scatter, the smoothed sensor (normal 
or swelling) data vs. errors (false positive or false 
negative). We defined each data in four quadrants as 
follow:  
§ Normal: High Sensor Value, Low Error 
 
Figure 4. Data Visualization on 




§ False Negative: High Sensor Value, High Error 
§ Swelling: Low Sensor Value, Low Error 
§ False Positive: Low Sensor Value, High Error 
 
Using K-means with a K of 4, we separated the four 
clusters for real-time classification. Through this 
process, we obtained a smoothed sensor value, its 
classification (whether or not swelling), and a 
confidence level based on the error vector. 
 
Figure 5: Raw sample flex data (blue line) and 
smoothed data (red line) with N =1, 6, 14, and 10 from 
top-left corner clockwise. We found N=10 to be the best 
window size to reduce noise without overly smoothing the 
data. In this dataset, we identified two “bumps” at 50 secs and 
150 secs that were caused by motion artifacts as these were 
classified as a false negative. There is a slight low, downward 
trend between the two bumps, which our classifier determines 
as mild swelling. 
Preliminary results 
We pilot tested SwellFit with 4 adults for 4 days. Our 
pilot study demonstrated that SwellFit adequately 
performed its data logging abilities. Also, SwellFit was 
robust enough to daily activities (including exercise, 
bicycling). Wearing it did not cause discomfort due to 
warmth or constriction and the sensor was robust 
enough to rotational force.  
The signal-processed data demonstrated that SwellFit 
successfully differentiates swelling from motion artifacts 
(e.g., change in values caused by sensor rotation, 
external force, etc.). The classification of data using the 
k-Means algorithm allowed SwellFit to identify when 
abnormal swelling happened. 
Conclusion and future work 
Congestive heart failure is a chronic condition that 
causes a significant medical and economic burden to 
both patients and the society. As part of the efforts to 
reduce unplanned readmission rates causes by CHF and 
to enhance self-management of CHF care, we designed 
SwellFit, a personal, non-obtrusive, wearable sensor 
that monitors ankle swelling. A pilot test with 4 adults 
showed that SwellFit successfully distinguishes noise 
data and motion artifacts from ankle swelling. 
Collaborating with cardiac experts, we are currently 
planning to test SwellFit with hospitalized CHF patients 
who have swelling conditions to demonstrate the 
feasibility and reliability of SwellFit of detecting swelling 
from ankle curvature. Once we validate the reliability 
and the feasibility of SwellFit, we will deploy it to CHF 
  
patients and evaluate its usefulness in real-world 
settings. We are hopeful that the successful 
development and deployment of SwellFit will help 
prevent unplanned readmission rates caused by CHF 
and enhance self-management of CHF. 
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